| Company Name: | Aspect Medical Systems Incorporated | | Ticker Symbol: | ASPM | | | WWW Address: | www.aspectms.com |
| CEO: | Nassib G. Chamoun | | No. of Employees: | 322 |
| Common Issue Type: | CS | | Business Description: | The company develops, manufactures and markets an anesthesia monitoring system.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 12.27 | 0.0 | - | - | | 12.27 | 12.27 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 214.1 | 17.4 | 1.51 | 0.56 | 0.00 | 24.1 | 0.0 | 12.30 - 2.50 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 12.27 | $ | | PE Ratio - LTM | 24.1 | |
| Market Capitalisation | 214.1 | mil |
| Latest Shares Outstanding | 17.4 | mil |
| Earnings pS (EPS) | 0.56 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 308,283 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 16.0 | mil |
| Float as % of Shares Outstanding | 91.8 | % |
| Foreign Sales | 30 | mil |
| Domestic Sales | 69 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 61.60 | % |
| Research & Devlopment (R&D) as % of Revenue | 16.20 | % |
| Gross Profit Margin | 78.2 | % |
| EBITDA Margin | 0.4 | % |
| Pre-Tax Profit Margin | 18.0 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | 7.6 | % |
| Return on Equity (ROE) | 16.6 | % |
| Return on Capital Invested (ROCI) | 8.6 | % |
| Current Ratio | 6.8 | |
| Leverage Ratio (Assets/Equity) | 2.2 | |
| Interest Cover | 10.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.93 | |
| LT Debt/Total Capital | 48.0 | % |
| Working Capital pS | 5.35 | $ |
| Cash pS | 1.54 | $ |
| Book-Value pS | 3.59 | $ |
| Tangible Book-Value pS | 3.55 | $ |
| Cash Flow pS | 0.77 | $ |
| Free Cash Flow pS | 0.23 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.42 | |
| Price/Tangible Book Ratio | 3.46 | |
| Price/Cash Flow | 15.8 | |
| Price/Free Cash Flow | 54.3 | |
| P/E as % of Industry Group | 83.0 | % |
| P/E as % of Sector Segment | 8.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
| 
|  | | Share price performance intraday |
| 
| |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 98 | 785 | |
| 4 Weeks | 12.30 | 11.97 | 11.98 | 2.4 | 102 | 993 | 19,858 |
| 13 Weeks | 12.30 | 5.10 | 5.32 | 130.6 | 212 | 2,364 | 151,272 |
| 26 Weeks | 12.30 | 4.97 | 5.19 | 136.4 | 191 | 1,585 | 201,265 |
| 52 Weeks | 12.30 | 2.50 | 3.06 | 301.0 | 320 | 1,225 | 307,421 |
| YTD | 12.30 | 2.86 | - | 259.8 | 297 | 1,211 | 266,422 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 12.27 | 12.16 | 10.63 | 7.33 | 6.45 | 1.51 | 1.31 |
|
| |
| GROWTH RATES | 5-Year Growh | R² of 5-Year Growth | 3-Year Growth |
| Revenue | 12.53 | 81.6 | 3.50 |
| Income | 0.00 | 0.0 | -13.24 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 25.79 | NA | -11.68 |
| R&D | 17.61 | NA | 6.43 |
| Normalized Inc. | 0.00 | NA | 4.25 |
| | | CHANGES | YTD vs. Last YTD | Curr Qtr vs. Qtr 1-Yr ago | Annual vs. Last Annual |
| Revenue % | 2.8 | 6.0 | 2.0 |
| Earnings % | -26.3 | -100.0 | 392.1 |
| EPS % | -31.3 | -100.0 | 409.1 |
| EPS $ | -0.05 | -0.07 | 0.45 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 67.15 |
| Current Ratio | 6.8 |
| Quick Ratio (Acid Test) | 5.9 |
| Liquidity Ratio (Cash) | 5.02 |
| Receivables Turnover | 7.7 |
| Average Collection Period | 47 |
| Working Capital/Equity | 164.2 |
| Working Capital pS | 5.30 |
| Cash-Flow pS | 0.81 |
| Free Cash-Flow pS | 0.31 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.78 |
| Financial Leverage Ratio (Assets/Equity) | 2.4 |
| Debt Ratio | 59.1 |
| Total Debt/Equity (Gearing Ratio) | 1.16 |
| LT Debt/Equity | 1.16 |
| LT Debt/Capital Invested | 53.8 |
| LT Debt/Total Liabilities | 80.4 |
| Interest Cover | 7.0 |
| Interest/Capital Invested | 2.81 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 4.71 |
| Tobin's Q Ratio | 1.56 |
| Current P/E Ratio - LTM | 24.10 |
| Enterprise Value (EV)/EBITDA | -67.86 |
| Enterprise Value (EV)/Free Cash Flow | 43.97 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.46 |
| Price/Book Ratio - LTM | 3.42 |
| Price/Cash Flow Ratio | 15.8 |
| Price/Free Cash Flow Ratio - LTM | 54.3 |
| Price/Sales Ratio | 2.11 |
| P/E Ratio (1 month ago) - LTM | 23.5 |
| P/E Ratio (26 weeks ago) - LTM | 7.9 |
| P/E Ratio (52 weeks ago) - LTM | 18.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 83.0 |
| P/E as % of Sector Segment | 8.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 12.4 |
| PER SHARE FIGURES |
| LT Debt pS | 3.75 |
| Current Liabilities pS | 0.91 |
| Tangible Book Value pS - LTM | 3.55 |
| Book Value pS - LTM | 3.59 |
| Capital Invested pS | 6.94 |
| Cash pS - LTM | 1.54 |
| Cash Flow pS - LTM | 0.77 |
| Free Cash Flow pS - LTM | 0.23 |
| Earnings pS (EPS) | 0.56 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.37 |
| Free Cash Flow Margin 5YEAR AVG | 4.51 |
| Net Profit Margin | 11.2 |
| Net Profit Margin - 5YEAR AVRG. | 14.1 |
| Equity Productivity | 1.77 |
| Return on Equity (ROE) | 19.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 18.8 |
| Capital Invested Productivity | 0.82 |
| Return on Capital Invested (ROCI) | 9.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 11.7 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | 8.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 10.1 |
| Gross Profit Margin | 78.2 |
| Gross Profit Margin - 5YEAR AVRG. | 78.0 |
| EBITDA Margin - LTM | 0.4 |
| EBIT Margin - LTM | 20.0 |
| Pre-Tax Profit Margin | 20.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 10.5 |
| Effective Tax Rate | 45.8 |
| Effective Tax Rate - 5YEAR AVRG. | -39.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 169 |
| Revenue per Employee | 308,283 |
| Net Income per Employee | 34,475 |
| Average Collection Period | 48 |
| Receivables Turnover | 7.7 |
| Day's Inventory Turnover Ratio | 121 |
| Inventory Turnover | 3.0 |
| Inventory/Sales | 7.9 |
| Accounts Payble/Sales | 2.17 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 1.08 |
| Fixed Assets Turnover | 3.39 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 8.23 |
| Revenue per $ Plant | 11.93 |
| Revenue per $ Common Equity | 1.77 |
| Revenue per $ Capital Invested | 0.82 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 64.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 57.9 |
| Research & Devlopment (R&D) as % of Revenue | 16.8 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 16.8 |
|
|  





|
| |
 |  |